Seminars in Hematology
Volume 45, Issue 1 , Pages 1-2 , January 2008

Myelodysplastic Syndromes: Introduction

References 

  1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649–1660
  2. de Witte T, Suciu S, Verhoef G, et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood. 2001;98:2326–2331
  3. de Witte T, Suciu S, Verhoef G, et al. Intensive chemotherapy followed by allogeneic or autologoius stem cell translantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood. 2002;98:2326–2331
  4. Wong R, Shahjahan M, Wang X, et al. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2005;11:108–114
  5. Jadersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellstrom-Lindberg E. Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood. 2005;
  6. van den BJ, Lubbert M, Verhoef G, Wijermans PW. The effects of 5-aza-2′-deoxycytidine (decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes. Leuk Res. 2004;28:785–790
  7. List A, Kurtin S, Roe DJ, et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med. 2005;352:549–557
  8. Silverman LR, Demakos EP, Peterson BL, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the Cancer and Leukemia Group B. J Clin Oncol. 2002;20:2429–2440
  9. Silverman LR. DNA methyltransferase inhibitors in myelodysplastic syndrome. Best Pract Res Clin Haematol. 2004;17:585–594
  10. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol. 1999;106:1027–1032
  11. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: Include and predisposing conditions. Leukemia. 1995;9:1569–1572
  12. Polychronopoulou S, Panagiotou JP, Kossiva L, et al. Clinical and morphological features of paediatric myelodysplastic syndromes: A review of 34 cases. Acta Paediatr. 2004;93:1015–1023
  13. McKenna RW. Myelodysplasia and myeloproliferative disorders in children. Am J Clin Pathol. 2004;122(suppl):S58–S69

PII: S0037-1963(07)00171-0

doi: 10.1053/j.seminhematol.2007.11.008

Seminars in Hematology
Volume 45, Issue 1 , Pages 1-2 , January 2008

Article Tools